Quadrant Capital Group’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,518
| Closed | -$11.5K | – | 2581 |
|
|
2025
Q1 | $11.5K | Hold |
2,518
| – | – | ﹤0.01% | 2188 |
|
|
2024
Q4 | $14.2K | Buy |
2,518
+1,316
| +109% | +$7.42K | ﹤0.01% | 2016 |
|
|
2024
Q3 | $5.82K | Sell |
1,202
-216
| -15% | -$1.05K | ﹤0.01% | 2286 |
|
|
2024
Q2 | $6.92K | Buy |
1,418
+1,268
| +845% | +$6.19K | ﹤0.01% | 2219 |
|
|
2024
Q1 | $1.99K | Hold |
150
| – | – | ﹤0.01% | 2511 |
|
|
2023
Q4 | $2.09K | Sell |
150
-42
| -22% | -$585 | ﹤0.01% | 2466 |
|
|
2023
Q3 | $2.55K | Hold |
192
| – | – | ﹤0.01% | 2327 |
|
|
2023
Q2 | $3.6K | Buy |
+192
| New | +$3.6K | ﹤0.01% | 2281 |
|